引用次数
引用: 30,567
H-指数: 53
I10-指数 : 115
出版物: 324
New insights into the genetic basis of neuroblastoma
Vandesompele J , Speleman F , Van Roy N , De Preter K
Verhandelingen - Koninklijke Academie voor Geneeskunde van België 69 ( 4) 167 -196
2007
Aberrant splicing of the PTPRD gene mimics microdeletions identified at this locus in neuroblastomas.
Prakash Nair , Katleen DePreter , Jo Vandesompele , Frank Speleman
Genes, Chromosomes and Cancer 47 ( 3) 197 -202
21
2008
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma
Johannes H. Schulte , Hagen S. Bachmann , Bent Brockmeyer , Katleen DePreter
Clinical Cancer Research 17 ( 15) 5082 -5092
126
2011
The miR-17–92 gene cluster is amplified and overexpressed in retinoblastoma
E Biewald , P Mestdagh , H Stephan , K de Preter
Klinische Padiatrie 221 ( 3) 4
2009
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
A Schramm , B Schowe , K Fielitz , M Heilmann
British Journal of Cancer 107 ( 8) 1409 -1417
19
2012
MYCN transcriptionally represses CD9 to trigger an invasion-metastasis cascade in neuroblastoma
Johannes Fabian , Desirée Opitz , Kristina Althoff , Marco Lodrini
Molecular and Cellular Pediatrics 2 ( 1) 1 -5
2015
Neuroblastoma prognostic multigene expression signature
Joke Vandesompele , Katleen Preter , Pieter Mestdagh , Franki Speleman
2
2011
Sarcocystis in bovine eosinophilic myositis: Contribution to pathogenesis
L. Vangeel , K. Houf , P. Geldhof , H. Nollet
Journal of Comparative Pathology 141 ( 4) 266 -266
1
2009
TREATMENT OF NEUROBLASTOMA: GENETICALLY INSPIRED FUTURE PERSPECTIVES
B DE WILDE , T VAN MAERKEN , K DE PRETER , N VAN ROY
TIJDSCHRIFT VOOR GENEESKUNDE 70 ( 22) 1326 -1335
2014
Characterization of the NOTCH1-driven miRNA network that controls normal human T-cell development. (HEM4P.246)
Kaat Durinck , Peter Pipelers , Pieter Rondou , Tom Taghon
Journal of Immunology 192
2014
A detailed inventory of DNA copy number alterations in four commonly used Hodgkin lymphoma cell lines
Bruno Verhasselt , Bruce Poppe , Tom Feys , Franki Speleman
Acta Clinica Belgica 62 ( 4) 258 -258
1
2007
Gebruik van genexpresieanalyse in de aanpak van neuroblastoom bij kinderen
Jo Vandesompele , Franki Speleman , Filip Pattyn , Pieter Mestdagh
ONCO (NEDERLANDSE ED.) 3 ( 6) 209 -215
2009
The MYCN/miR-26a-5p/LIN28B regulatory axis controls MYCN-driven LIN28B upregulation in neuroblastoma
Anneleen Beckers , Jason Shohet , Jo Vandesompele , Franki Speleman
Advances in Neuroblastoma Research 2014 (ANR 2014)
2014
Synergistic combined molecular treatment targeting the HBP1 tumor suppressor gene in neuroblastoma
Tom Van Maerken , Anneleen Beckers , Alan Van Goethem , Candy Kumps
OncoPoint, 3rd Meeting, Abstracts
2015
Promoter DNA-methylation in the TH-MYCN neuroblastoma mouse model
Maté Ongenaert , Wouter Van Loocke , Anneleen Beckers , Jo Vandesompele
Advances in Neuroblastoma Research 2014 (ANR 2014)
2014
Characterization of ALK driven molecular networks identifies perturbed RET and cholinergic signaling in neuroblastoma
Piotr Zabrocki , Tom Van Maerken , Jan Cools , Johannes Schulte
Cancer Pharmacogenomics and Targeted Therapies, 2nd Wellcom Trust conference, Abstracts
2014
Genetisch geïnspireerde toekomstperspectieven voor de therapie van het neuroblastoom
Tom Van Maerken , Jo Vandesompele , Bram De Wilde , Franki Speleman
Tijdschrift Voor Geneeskunde 70 ( 22) 1326 -1335
1
2014
The MYCN driven murine and human neuroblastoma methylome and dynamic regulation of chromatin regulators as a guide for epigenetic therapy
Maté Ongenaert , Johannes H Schulte , Anneleen Beckers , Jo Vandesompele
Cancer Epigenomics, Cell symposia, Abstracts
2013
Genome-wide methylation analysis unravels differential DNA methylation patterns between (prognostic) neuroblastoma patient subgroups
Gudrun Schleiermacher , Deborah Tweddle , Maté Ongenaert , Valérie Combaret
Advances in Neuroblastoma Research 2014 (ANR 2014)
2014
The MYCN/miR-26a-5p/LIN28B regulatory axis explains MYCN driven LIN28B upregulation during mouse neuroblastoma development
Anneleen Beckers , Jason Shohet , Jo Vandesompele , Franki Speleman
OncoPoint, 2nd Meeting, Abstracts
2014